Muscarinic, Histamine H1, and Alpha Adrenergic Receptors

The term "Muscarinic, Histamine H1, and Alpha Adrenergic Receptors" refers to a pharmacological grouping of three distinct families of G protein-coupled receptors (GPCRs): muscarinic acetylcholine receptors (primarily M1–M5), histamine H1 receptors, and alpha-adrenergic receptors (mainly alpha-1 and alpha-2 subtypes). These receptors are individually considered important therapeutic targets in neurology, psychiatry, allergy, and cardiovascular medicine. Many drugs, especially older antipsychotics, tricyclic antidepressants, and first-generation antihistamines, non-selectively interact with two or more of these receptors, leading to both desired effects (e.g., antiallergic action, calming, vasodilation) and prominent adverse effects (e.g., sedation, weight gain, anticholinergic symptoms, orthostatic hypotension)[1][2][3][4][5][6][7]. Note: For structured data, it is strongly recommended to split this grouping into three canonical entries: 1. Muscarinic acetylcholine receptor (M receptor) 2. Histamine H1 receptor (H1 receptor) 3. Alpha-adrenergic receptor (α-adrenoceptor, specify alpha-1 or alpha-2 if known) Grouping as given is not standard nomenclature and is best avoided when possible[2][6].

Other names

Muscarinic receptorHistamine H1 receptorAlpha-adrenergic receptorAlpha-1 adrenergic receptorAlpha-2 adrenergic receptorM receptorH1 receptorα-adrenoceptor

Antagonism/blockade of muscarinic cholinergic receptors (anticholinergic effects) - Antagonism/blockade of histamine H1 receptor (antihistaminic effects) - Antagonism/blockade of alpha-adrenergic receptors (antiadrenergic, primarily alpha-1, effects) These mechanisms mediate effects such as sedation, prevention of allergic symptoms, hypotension, and weight gain[1][2][3][5][6].